04 July 2018 : Case report
Nivolumab Immunotherapy in Malignant Mesothelioma: A Case Report Highlighting a New Opportunity for Exceptional Outcomes
Unusual or unexpected effect of treatment, Unexpected drug reaction, Rare disease
DOI: 10.12659/AJCR.909584
Am J Case Rep 2018; 19:783-789
HTML version available soon